135
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

A Response to Seed et al, Regarding Choices of New Opioid Formulations

, MD
Pages 64-65 | Published online: 13 Mar 2015

References

  • . Seed SM, Dunican KC, Lynch AM, Desilets AR. An update in options for the treatment of pain: a review of new opioid formulations. Hosp Pract (Minneap). 2012;40(1):166–175
  • . Rappaport RA. Division Director's Review and Summary Basis for Approval NDA 200533: US Food and Drug Administration; 2011
  • . OPANA® ER [package insert]. Chadds Ford, PA: Endo Pharmaceuticals Inc.; 2012
  • . Bartholomaeus JH, Arkenau-Marić E, Galia E. Opioid extended-release tablets with improved tamper-resistant properties. Expert Opin Drug Deliv. 2012;9(8):879–891
  • . Duragesic® (fentanyl transdermal system) [package insert]. Titusville, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; 2009
  • . EXALGO® ER (hydromorphone HCl extended-release tablets) [package insert]. Hazelwood, MO: Mallinckrodt (Covidies); 2010
  • . Benedek IH, Jobes J, Xiang Q, Fiske WD. Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release. Drug Des Devel Ther. 2011;5:455–463
  • . Fiske WD, Jobes J, Xiang Q, Chang SC, Benedek IH. The effects of ethanol on the bioavailability of oxymorphone extended-release tablets and oxymorphone crush-resistant extended-release tablets. J Pain. 2012;13(1):90–99
  • . Chou R, Fanciullo GJ, Fine PG, . Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130
  • . Viscusi ER, Pappagallo M. A review of opioids for in-hospital pain management. Hosp Pract (Minneap). 2012;40(1):149–159

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.